Carregant...

Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion

Background and aims: Lamivudine induces favourable virological and biochemical responses but post-treatment relapses are frequent, even in patients with hepatitis B e antigen (HBeAg) loss or seroconversion. The aim of this study was to determine whether extended lamivudine therapy for up to 12 month...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lee, H C, Suh, D J, Ryu, S H, Kim, H, Shin, J W, Lim, Y-S, Chung, Y-H, Lee, Y S
Format: Artigo
Idioma:Inglês
Publicat: Copyright 2003 by Gut 2003
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773893/
https://ncbi.nlm.nih.gov/pubmed/14633962
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!